Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Navarro

Showing results (71-80 of 936) with videos related to

Pageof 94
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|November 13, 2004
Behavioral profile of SB 269970, a selective 5-HT(7) serotonin receptor antagonist, in social encounters between male miceJ F Navarro, M Ibáñez, G Luna
Current Topics in Microbiology and Immunology|August 24, 1999
A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cellsM Colonna, F Navarro, M López-Botet
Lancet (London, England)|September 30, 1995
Long-term hospital support for dialysisJ F Navarro, C Mora, M Martos
International Journal of Cardiology|July 1, 1992
Cardiac tamponade as presentation of systemic amyloidosisJ F Navarro, M Rivera, J Ortuño
Anales De Medicina Interna (Madrid, Spain : 1984)|November 20, 2003
[Renal and hepatic failure secondary to cyanamide]A Rodríguez, M Macía, J F Navarro
Kidney International|June 9, 2000
Serum magnesium and parathyroid hormone levels in dialysis patientsJ F Navarro, C Mora, J Garcia
The New England Journal of Medicine|February 19, 2000
Nephropathy in type 2 diabetesC Mora, J Garcia, J F Navarro
Nephron|April 19, 2002
Intradialytic amino acid supplementationCarmen Mora, Candelaria León, Juan F Navarro
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|March 14, 2008
[Magnesium in chronic kidney disease]H Tapia, C Mora, J F Navarro
Nephron|September 16, 1998
Effect of angiotensin-converting enzyme inhibitors on hematological parameters and recombinant human erythropoietin doses in peritoneal dialysis patientsJ F Navarro, C Mora, A Rivero
Pageof 94

Showing results (71-80 of 936) with videos related to

Sort By:
Pageof 94
Methods and Findings in Experimental and Clinical Pharmacology|November 13, 2004
Behavioral profile of SB 269970, a selective 5-HT(7) serotonin receptor antagonist, in social encounters between male miceJ F Navarro, M Ibáñez, G Luna
Current Topics in Microbiology and Immunology|August 24, 1999
A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cellsM Colonna, F Navarro, M López-Botet
Lancet (London, England)|September 30, 1995
Long-term hospital support for dialysisJ F Navarro, C Mora, M Martos
International Journal of Cardiology|July 1, 1992
Cardiac tamponade as presentation of systemic amyloidosisJ F Navarro, M Rivera, J Ortuño
Anales De Medicina Interna (Madrid, Spain : 1984)|November 20, 2003
[Renal and hepatic failure secondary to cyanamide]A Rodríguez, M Macía, J F Navarro
Kidney International|June 9, 2000
Serum magnesium and parathyroid hormone levels in dialysis patientsJ F Navarro, C Mora, J Garcia
The New England Journal of Medicine|February 19, 2000
Nephropathy in type 2 diabetesC Mora, J Garcia, J F Navarro
Nephron|April 19, 2002
Intradialytic amino acid supplementationCarmen Mora, Candelaria León, Juan F Navarro
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|March 14, 2008
[Magnesium in chronic kidney disease]H Tapia, C Mora, J F Navarro
Nephron|September 16, 1998
Effect of angiotensin-converting enzyme inhibitors on hematological parameters and recombinant human erythropoietin doses in peritoneal dialysis patientsJ F Navarro, C Mora, A Rivero
Pageof 94